Skip to main content

$0.120 0.010 (9.09%)

High

$0.12

Low

$0.11

Trades

74

Turnover

$139,612

Volume

1,216,523
30 June 2023 at 4:10pm
Register to track CAN and receive email alerts.

Clinical trial recruitment target met

StockBot

416,823 posts

CAN released this announcement to the ASX on 11 October 2022, 9:01. The announcement is not marked as price sensitive, and is 2 page(s) in length and 202.76kb in size.

You can view all announcements from CAN and see how they appear on a price chart on the announcements page.

At the date of this announcement, CAN was 0.000% short sold according to ASIC data. It was ranked the 657th most shorted stock on the ASX. It is now ranked as the 643rd most shorted stock on the ASX with 0.000% of total shares short sold as of the latest reported data (04 June 2024).

Other Recent Announcements from CAN
Dr Julian Chick appointed as Deputy Chair 27 June 2023, 8:16
Shareholder and Investor Webinar 26 June 2023, 14:22
Letter to ineligible shareholders 23 June 2023, 8:18
Clinical trial recruitment target met 11 October 2022, 9:01
Scope of Mildura GMP licence extended 4 October 2022, 14:06
Resignation and appointment of Company Secretary 3 October 2022, 10:29
Change of address - corporate and registered office 3 October 2022, 10:29
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track CAN and receive email alerts.